213 related articles for article (PubMed ID: 17507470)
1. Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor.
Ohka S; Igarashi H; Nagata N; Sakai M; Koike S; Nochi T; Kiyono H; Nomoto A
J Virol; 2007 Aug; 81(15):7902-12. PubMed ID: 17507470
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of dissemination pathways for poliovirus].
Ohka S
Uirusu; 2009 Jun; 59(1):107-14. PubMed ID: 19927995
[TBL] [Abstract][Full Text] [Related]
3. Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation.
Khan S; Toyoda H; Linehan M; Iwasaki A; Nomoto A; Bernhardt G; Cello J; Wimmer E
J Gen Virol; 2014 Aug; 95(Pt 8):1668-1676. PubMed ID: 24784416
[TBL] [Abstract][Full Text] [Related]
4. Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons.
Ohka S; Sakai M; Bohnert S; Igarashi H; Deinhardt K; Schiavo G; Nomoto A
J Virol; 2009 May; 83(10):4995-5004. PubMed ID: 19244317
[TBL] [Abstract][Full Text] [Related]
5. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome.
Ohka S; Matsuda N; Tohyama K; Oda T; Morikawa M; Kuge S; Nomoto A
J Virol; 2004 Jul; 78(13):7186-98. PubMed ID: 15194795
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway.
Ohka S; Nihei C; Yamazaki M; Nomoto A
Front Microbiol; 2012; 3():147. PubMed ID: 22529845
[TBL] [Abstract][Full Text] [Related]
7. Multiple pathways for establishment of poliovirus infection.
Arita M; Ohka S; Sasaki Y; Nomoto A
Virus Res; 1999 Aug; 62(2):97-105. PubMed ID: 10507320
[TBL] [Abstract][Full Text] [Related]
8. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.
Lancaster KZ; Pfeiffer JK
PLoS Pathog; 2010 Mar; 6(3):e1000791. PubMed ID: 20221252
[TBL] [Abstract][Full Text] [Related]
9. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus.
Ida-Hosonuma M; Iwasaki T; Yoshikawa T; Nagata N; Sato Y; Sata T; Yoneyama M; Fujita T; Taya C; Yonekawa H; Koike S
J Virol; 2005 Apr; 79(7):4460-9. PubMed ID: 15767446
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor.
Yanagiya A; Ohka S; Hashida N; Okamura M; Taya C; Kamoshita N; Iwasaki K; Sasaki Y; Yonekawa H; Nomoto A
J Virol; 2003 Oct; 77(19):10479-87. PubMed ID: 12970433
[TBL] [Abstract][Full Text] [Related]
11. Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut.
Zhang S; Racaniello VR
J Virol; 1997 Jul; 71(7):4915-20. PubMed ID: 9188553
[TBL] [Abstract][Full Text] [Related]
12. Poliovirus-sensitive transgenic mice as a new animal model.
Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of poliovirus neurovirulence.
Ohka S; Nomoto A
Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
[TBL] [Abstract][Full Text] [Related]
14. The poliovirus receptor: identification of domains and amino acid residues critical for virus binding.
Bernhardt G; Harber J; Zibert A; deCrombrugghe M; Wimmer E
Virology; 1994 Sep; 203(2):344-56. PubMed ID: 7914388
[TBL] [Abstract][Full Text] [Related]
15. The risk of unintentional propagation of poliovirus can be minimized by using human cell lines lacking the functional CD155 gene.
Koike S
Microbiol Immunol; 2020 Dec; 64(12):835-839. PubMed ID: 32902876
[TBL] [Abstract][Full Text] [Related]
16. N glycosylation of the virus binding domain is not essential for function of the human poliovirus receptor.
Zibert A; Wimmer E
J Virol; 1992 Dec; 66(12):7368-73. PubMed ID: 1331527
[TBL] [Abstract][Full Text] [Related]
17. Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.
Crotty S; Hix L; Sigal LJ; Andino R
J Gen Virol; 2002 Jul; 83(Pt 7):1707-1720. PubMed ID: 12075090
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.
Freistadt MS; Eberle KE
Microb Pathog; 2000 Oct; 29(4):203-12. PubMed ID: 10993739
[TBL] [Abstract][Full Text] [Related]
19. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction.
Solecki D; Gromeier M; Harber J; Bernhardt G; Wimmer E
J Mol Recognit; 1998; 11(1-6):2-9. PubMed ID: 10076797
[TBL] [Abstract][Full Text] [Related]
20. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
